iTeos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	251.45	285.04	848.84	336.45	19.99	22.05
Short-Term Investments	280.74	328.36	0	0	0	0
Cash & Cash Equivalents	532.19	613.4	848.84	336.45	19.99	22.05
Cash Growth	-13.24%	-27.74%	152.29%	1583.11%	-9.36%	-
Receivables	0	1	4.02	0.13	5.2	1.09
Other Current Assets	18.46	13.9	21.86	2.96	0.89	0.53
Total Current Assets	550.65	628.3	874.71	339.54	26.08	23.67
Property, Plant & Equipment	10.73	6.77	7.4	1.35	1.34	1.16
Long-Term Investments	100.54	118.23	0	0	0	0
Other Long-Term Assets	5.67	1.7	2.6	3.66	3.33	2.56
Total Long-Term Assets	116.94	126.69	10	5.01	4.67	3.72
Total Assets	667.59	754.99	884.71	344.56	30.74	27.39
Accounts Payable	21.08	7.66	5.15	3.03	1.17	1.37
Deferred Revenue	2.06	13.78	281.05	4.49	2.36	0.39
Current Debt	1.25	0.84	0.77	0	0	0
Other Current Liabilities	15.62	19.73	17.16	7.49	9.66	3.26
Total Current Liabilities	40.01	42	304.12	15	13.2	5.01
Long-Term Debt	4.81	3.84	4.57	0	0	0
Other Long-Term Liabilities	47.54	45.82	23.2	6.36	1.88	7.32
Total Long-Term Liabilities	52.35	49.66	27.77	6.36	1.88	7.32
Total Liabilities	92.36	91.66	331.89	21.36	15.08	12.34
Total Debt	6.06	4.67	5.34	0	0	0
Debt Growth	29.64%	-12.51%	-	-	-	-
Retained Earnings	124.63	237.28	140.62	-73.9	-35.87	-10.77
Comprehensive Income	-13.24	-9.64	-1.02	0.62	-0.22	-0.01
Shareholders' Equity	575.23	663.33	552.82	323.2	-36.09	-10.68
Net Cash / Debt	526.13	608.72	843.49	336.45	19.99	22.05
Net Cash / Debt Growth	-13.57%	-27.83%	150.70%	1583.11%	-9.36%	-
Net Cash Per Share	14.71	16.12	22.33	22.31	98.57	35.86
Working Capital	510.64	586.3	570.59	324.55	12.88	18.66
Book Value Per Share	16.08	18.66	15.71	21.43	-177.96	-17.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).